Last reviewed · How we verify
NCT06099938
Effect of Different Labour Analgesics on Maternal and Fetal Blood Flow Observed by Doppler Ultrasonography
trial testing sufentanil, ropivacaine in Labor Pain in 90 participants. Completed in 1 January 2022.
1 December 2021
Quick facts
| Lead sponsor | First Affiliated Hospital of Jinan University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 90 |
| Start date | 1 March 2021 |
| Primary completion | 1 December 2021 |
| Estimated completion | 1 January 2022 |
| Sites | 1 location across China |
Drugs / interventions tested
- sufentanil, ropivacaine — full drug profile →
Conditions studied
- Labor Pain — all drugs for Labor Pain →
- Analgesia — all drugs for Analgesia →
- Fetus Disorder — all drugs for Fetus Disorder →
Sponsor
First Affiliated Hospital of Jinan University
Who can join
Adults 20 to 35, female only, with Labor Pain or Analgesia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background: The purpose of this study was to see how intrathecal injections of sufentanil, ropivacaine, and sufentanil added to ropivacaine affected blood flow in the uterine artery, umbilical artery, and middle cerebral artery for combined spinal and epidural labor analgesia using color doppler ultrasound (CDUs). Methods: A total of 90 singleton full-term parturients who were evaluated by obstetricians for feasible vaginal delivery were collected prospectively and divided into three groups based on the randomization and double-blind principle: sufentanil (S), ropivacaine (R) group, each with 30 cases. Main indicators include color doppler blood flow resistance indices (S/D) of the uterine artery (UtA), umbilical artery (UA), and middle cerebral artery (MCA) before (T0) and 30 minutes (T1), 60 minutes (T2), 90minutes (T3) after analgesia. Fetal heart rate (FHR), maternal mean arterial pressure (MAP) at T0, T1, T2 and T3。
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06099938
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Labor Pain
Currently open trials in the same condition.
- NCT07440069 — Analgesic Efficacy and Obstetric Effects of Tramadol, Paracetamol and Placebo in Active Labor · Phase 4 · recruiting
- NCT07411352 — Left Lateral Position vs Supine Position to Reduce Active Labor Duration · NA · recruiting
- NCT07401147 — Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Management During Labor. · NA · recruiting
- NCT07395934 — Comparing PIEB and CEI for Labor Pain Relief · NA · recruiting
- NCT06819579 — Exploring the Optimal Concentration of Lidocaine Test Dose for Labor Analgesia · NA · active not recruiting
Other First Affiliated Hospital of Jinan University trials
Trials by the same sponsor.
- NCT06752954 — The Effectiveness of Covered Stent Viabahn and Drug-coated Balloon for Complex Femoropopliteal Artery Lesions · not yet recruiting
- NCT05888558 — Screening of Serum Exosomal miRNA as a Biomarker for Ocular Muscle Myasthenia Gravis · unknown
- NCT06286384 — Evaluating the Long-term Effects of Microfocused Ultrasound on Facial Tightening Using Quantitative Instruments · completed
- NCT04906031 — Sodium Stibogluconate in the MDS/AML With One of the 65 Defined p53 Mutations · Phase 2 · unknown
- NCT03807986 — The Combination Therapy of Nanofat Grafting and PRP Compared With Microfat Grafting and PRP Synergy in Treating Striae D · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06099938 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by First Affiliated Hospital of Jinan University
- Last refreshed: 25 October 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06099938.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing